Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies
AUTOR(ES)
Mello, Vanessa Azevedo de, Ricci-Júnior, Eduardo
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2011
RESUMO
Nanoparticles were produced by solvent emulsification evaporation method with the following characteristics: nanometric size (238 ± 3 nm), narrow polydispersity index (0.11), negative zeta potential (-15.1 mV), good yield of the process (73 ± 1.5%), excellent encapsulation efficiency (81.3 ± 4.2%) and spherical shape. X-rays diffraction demonstrated the loss of drug crystallinity after encapsulation; however, the profile of the diffractograms of the poly-ε-caprolactone (PCL) nanoparticles was kept. Differential scanning calorimetry thermograms, correspondingly, exhibited the loss of drug melting peak and the increasing of the melting point of the PCL nanoparticles, evidencing an interaction drug-polymer. Naproxen release was low and sustained obeying the Higuchi´s kinetic. The results show that nanoparticles are promising sustained release system to the naproxen.
Documentos Relacionados
- Interaction of naproxen with calcium carbonate: physicochemical characterization and in vitro drug release studies
- Characterization and in vitro release studies of tetracycline and rolitetracycline imobilized on anionic collagen membranes
- Studies of Thermal Stability of Multivalent DNA Hybridization in a Nanostructured System
- Improved dissolution and micromeritic properties of naproxen from spherical agglomerates: preparation, in vitro and in vivo characterization
- Development and characterization of PLGA nanocapsules of grandisin isolated from Virola surinamensis: in vitro release and cytotoxicity studies